ALIGOS THERAPEUTICS INC's ticker is ALGS and the CUSIP is 01626L105. A total of 78 filers reported holding ALIGOS THERAPEUTICS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,395 | -23.1% | 39,351 | 0.0% | 0.00% | – |
| Q2 2023 | $38,210 | +11.1% | 39,351 | 0.0% | 0.00% | – |
| Q1 2023 | $34,393 | +10.7% | 39,351 | +20.7% | 0.00% | – |
| Q4 2022 | $31,068 | -13.7% | 32,604 | 0.0% | 0.00% | – |
| Q3 2022 | $36,000 | -7.7% | 32,604 | 0.0% | 0.00% | – |
| Q2 2022 | $39,000 | -90.5% | 32,604 | -83.0% | 0.00% | – |
| Q1 2022 | $412,000 | -83.0% | 191,827 | -5.9% | 0.00% | – |
| Q4 2021 | $2,420,000 | -21.3% | 203,799 | +2.8% | 0.00% | -100.0% |
| Q3 2021 | $3,076,000 | -15.2% | 198,311 | +11.4% | 0.00% | 0.0% |
| Q2 2021 | $3,629,000 | +40.4% | 178,014 | +56.6% | 0.00% | – |
| Q1 2021 | $2,584,000 | -21.7% | 113,640 | -4.8% | 0.00% | -100.0% |
| Q4 2020 | $3,301,000 | – | 119,387 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 2,320,381 | $1,733,325 | 0.92% |
| TANG CAPITAL MANAGEMENT LLC | 3,329,048 | $2,486,799 | 0.35% |
| Vivo Capital, LLC | 3,547,030 | $2,649,631 | 0.29% |
| Pivotal bioVenture Partners Investment Advisor LLC | 743,215 | $555,182 | 0.22% |
| Newtyn Management, LLC | 920,000 | $687,240 | 0.17% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 631,887 | $472,020 | 0.14% |
| EcoR1 Capital, LLC | 3,948,360 | $2,949,425 | 0.10% |
| HHLR ADVISORS, LTD. | 2,309,764 | $1,725,394 | 0.04% |
| Baker Brothers Advisors | 2,076,400 | $1,551,071 | 0.01% |
| HARBOURVEST PARTNERS LLC | 18,783 | $14,031 | 0.01% |